Is ARNI or VICI a better dividend investment in 2026?

ARNI currently yields 1000000.00% with a 5% 5-year dividend growth rate. VICI yields 6.57% with 8.1% growth. The better choice depends on your goal: ARNI offers higher current income.

What is the dividend yield difference between ARNI and VICI?

ARNI has a forward dividend yield of 1000000.00% ($2.00/share annually). VICI yields 6.57% ($1.78/share annually). The yield gap is 999993.43 percentage points.

Home › Compare › ARNI vs VICI

ARNI vs VICI: Dividend Comparison 2026

ARNI yields 1000000.00% · VICI yields 6.57%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARNI wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARNI

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full ARNI calculator →

VICI

VICI Properties Inc.

● Live price

6.57%

Share price

$27.12

Annual div

$1.78

5Y div CAGR

44.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$988.8K

Annual income

$623,261.32

Full VICI calculator →

Portfolio growth — ARNI vs VICI

📍 ARNI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARNI	VICI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARNI + VICI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARNI pays

VICI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARNI

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

VICI

Annual income on $10K today (after 15% tax)

$558.67/yr

After 10yr DRIP, annual income (after tax)

$529,772.12/yr

At 15% tax rate, ARNI beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARNI + VICI for your $10,000?

ARNI: 50%VICI: 50%

100% VICI50/50100% ARNI

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

ARNI

No analyst data

Altman Z

-76.9

Piotroski

2/9

VICI

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$31.60

+16.5% upside vs current

Range: $30.00 — $33.00

Altman Z

1.4

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARNI buys

VICI buys

No recent congressional trades found for ARNI or VICI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARNIVICI

Forward yield	1000000.00% ✓	6.57%
Annual dividend / share	$2.00 ✓	$1.78
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	44.3% ✓
Portfolio after 10y	$4.7683925249533696e+36M	$988.8K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$623,261.32
Total dividends collected	$4.7683311610149396e+36M	$948.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: ARNI vs VICI ($10,000, DRIP)

Year	ARNI Portfolio	ARNI Income/yr	VICI Portfolio	VICI Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,368	$948.43	+$100.00M → ARNI
2	$934,786,450,701	$934,679,439,252.34	$13,339	$1,493.16	+$934786.44M → ARNI
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$16,326	$2,426.21	+$8165787108.56M → ARNI
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$21,123	$4,112.15	+$66665884190957.63M → ARNI
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$29,379	$7,368.23	+$508662171058048128.00M → ARNI
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$44,804	$14,191.64	+$3.62723524842849e+21M → ARNI
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$76,658	$29,972.12	+$2.417368115915061e+25M → ARNI
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$150,894	$71,015.81	+$1.5056740286145463e+29M → ARNI
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$350,814	$193,582.47	+$8.764771002818475e+32M → ARNI
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$988,809	$623,261.32	+$4.7683925249533696e+36M → ARNI

ARNI vs VICI: Complete Analysis 2026

ARNI — Stock

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.

Full ARNI Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →

📬

Get this ARNI vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARNI vs SCHD ARNI vs JEPI ARNI vs O ARNI vs KO ARNI vs MAIN ARNI vs NNN ARNI vs EPRT ARNI vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.